Menu

Recent Interviews

Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

info@krl.com.sg

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".


Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


John Jeffrey, CEO, Saturn Oil + Gas Inc.

John Jeffrey
CEO | Saturn Oil + Gas Inc.
Suite 1000 - 207 9 Ave SW, T2P 1K3 Calgary (CAN)

info@saturnoil.com

+1-587-392-7900

Saturn Oil + Gas CEO John Jeffrey: "Acquisition has increased production by 2,000%"


08. February 2021 | 07:30 CET

Fresenius, Fresenius Medical Care, Q&M Dental: Healthy returns await here

  • Health
Photo credits: pixabay.com

Healthcare stocks have been in demand not just since the pandemic, but the pandemic is a sure game-changer for the industry in the long term. Demand for consumables and tests will continue to rise because this much seems certain: the Coronavirus will remain with us and possibly return year after year like a wave of influenza. Companies in the industry can profit from this. We present three stocks.

time to read: 2 minutes by Nico Popp
ISIN: SG2E73981531 , DE0005785604 , DE0005785802


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


Fresenius or Fresenius Medical Care?

If you're a casual investor looking at the price lists of German stocks, you're bound to notice Fresenius and Fresenius Medical Care. But what do these two companies do? In a nutshell, Fresenius is the parent Company and has a stake in Fresenius Medical Care. While Fresenius also operates hospitals and offers other products, such as infusions or nutrition, Fresenius Medical Care focuses entirely on dialysis. This form of blood washing helps patients with weak kidneys stay healthy and buy time until the kidneys can resume their function or a donor kidney can be transplanted. In addition to dialysis as a service, Fresenius Medical Care also offers dialysis products.

Even though the parent Company Fresenius profits about 50% from the dialysis business, the specialized subsidiary is more promising on the stock market. While Fresenius Medical Care effectively occupies a niche and can profit from trends such as aging society in the long term, Fresenius has to contend with hospital services and infusion. These two business segments are not doing well at the moment. During the peak phase of the pandemic, postponed surgery appointments also had a negative impact.

Fresenius Medical Care: Interesting at the three-year low despite everything

Comparing the shares of Fresenius and Fresenius Medical Care, the parent Company currently looks more favorably valued. Since Fresenius also has a stake of around 50% in the strong dialysis subsidiary, the share, which is considered boring, is worth considering for long-term investors. The services and infusion business has weakened recently, but this can be remedied. In the long term, Fresenius should be able to benefit from rising spending in the healthcare sector. Fresenius Medical Care recently shocked the market with a weak earnings forecast for 2021, which sent the stock on a downward slide close to its three-year low. However, those who take a long-term view can analyze this stock in more detail.

Q & M Dental: Asia invests in beautiful teeth

A share that is hardly known in Germany but has an attractive business model is Q & M Dental. The operator of 114 dental practices, five clinics and three distribution companies for medical products in Singapore, Malaysia and China already made a virtue out of necessity in the summer of 2020 and invested in a corona tests manufacturer. While the government supported the Company because of the collapsed business with dental treatments, Q&M pushed test procedures and is now a licensed partner of the Ministry of Health in Singapore for corona tests.

The go-getting management team also has its sights set on other regions of the world. Since Q & M Dental had already planned to expand even more in China and Malaysia before the pandemic, it has growth potential. A study by KGI, an Asian analyst firm, gave the stock a potential upside of nearly 20% at the end of November. Given Q & M's stable business in Singapore, the side earnings with Corona tests, and the expansion fantasy, the stock could be a welcome alternative for investors who find Asian healthcare stocks exciting.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

09. February 2021 | 08:00 CET | by Stefan Feulner

CureVac, Cardiol Therapeutics, Bayer - roaring profits!

  • Health

The race for the best and most effective vaccine is in full swing. After BioNTech and its partner Pfizer, Moderna and AstraZeneca were approved in Europe, but there are always obstacles. Over the weekend, for example, South Africa announced that it is forgoing the AstraZeneca vaccine for the time being. The background to this is its supposedly lower efficacy with the B.1.351 virus mutation. Somewhat unnoticed, another vaccine manufacturer is moving into pole position through innovative collaborations.

Read

28. January 2021 | 10:39 CET | by André Will-Laudien

Fresenius - Q&M Dental Group - IBU-tec: New price explosions every day!

  • Health

Rarely has the stock market been so volatile and exciting as in the last few days. Hedge fund Melvin Capital had to close out because of the GameStop share, and now the next wave is probably looming with AMC Entertainment. A full 270% went through the roof right at the opening; according to the New York Stock Exchange (NYSE) thousands of buy orders were already there at opening. Again, there had been a recommendation in a social media channel. On the Nasdaq, it jumped rapidly from USD 5 to USD 21 right at the opening - something you rarely see. And GameStop continues today after yesterday's debacle! After several trading suspensions, the value exploded further from USD 149 to USD 380 after a good hour of trading. That should have been the end of trading school for many new entrants!

Read

23. December 2020 | 08:50 CET | by André Will-Laudien

Q & M Dental, Moderna, AstraZeneca: Serving people!

  • Health

Rarely has the stock market been so focused on people as it has been during the pandemic. People are thinking about which companies offer the best service package for all the problems associated with infections, vaccinations and even the psychological effects of isolation and loneliness. Humans are "social animals" with multiple social needs. Curtailing these needs works temporarily, but at some point, the arguments have to be genuinely purposeful so that certain restrictions continue to be accepted. At the peak of the contagion curve, we would like to see possible remedies that quickly turn the overall situation into a positive end - this is possible for the medium-term future. Still, in the short term, we have to stick together.

Read